{
  "id": "CD015003.PUB2",
  "draft": "Can colchicine (an anti-inflammatory medicine) help prevent heart attacks, strokes, and other cardiovascular events in people who have not had any of these problems before?\n\nKey Messages\n- Colchicine may help reduce the risk of death from any cause in people who have not had any heart or blood vessel problems before, but we are not sure because the evidence is not strong enough. It may also increase the risk of diarrhea (loose, watery stools).\n- We do not know if colchicine can prevent heart attacks, strokes, or other cardiovascular events in people without a history of these problems. This is because the current evidence is not clear, and we need more research to understand its effects.\n- Future studies should look at the long-term effects of colchicine and its potential benefits and harms in preventing cardiovascular events. The current evidence is limited because the studies were small, and the participants may have known which treatment they were getting, which can affect the results.\n\nWhat are heart and blood vessel problems caused by clogged arteries?\nHeart and blood vessel problems caused by clogged arteries happen when fatty substances clog the arteries, leading to chronic inflammation and potentially life-threatening complications. It is a leading cause of death and disability around the world, putting a strain on healthcare systems and affecting the quality of life for millions of people. Current treatments often manage symptoms or reduce risks (like high blood pressure), but we need better ways to prevent these diseases from starting.\n\nWhat is colchicine and how might it help with heart and blood vessel problems?\nColchicine is a cheap drug with anti-inflammatory properties that has been used for centuries. It might help prevent heart and blood vessel problems because it can reduce inflammation, a key factor in the development of the disease. However, we still do not know if colchicine can prevent these heart and blood vessel problems for most people. We need more and better research to find out its true benefits and harms.\n\nWhat did the review authors want to find out?\nWe wanted to assess the benefits and harms of using colchicine to prevent cardiovascular events in people who have not had any of these problems before. We compared colchicine to a placebo (a dummy pill), other medicines that affect the body's immune system (called immunomodulating medications), or usual care to see if it could reduce the risk of cardiovascular outcomes like death from any cause, non-fatal heart attacks, stroke, and adverse events.\n\nHow did we find the evidence?\nWe searched for studies that compared colchicine to other treatments for preventing cardiovascular events. We summarized the results and rated how confident we are in the evidence.\n\nWhat did we find?\nWe found 15 studies that involved 1721 people. The studies lasted from 4 to 728 weeks. In these studies, researchers compared people taking colchicine by mouth to people taking a placebo, other anti-inflammatory drugs, or having usual care. Most of the studies focused on liver disease rather than the general population. Colchicine may reduce the risk of death from any cause, but we are very uncertain about the results. It may make little to no difference to the risk of non-fatal heart attacks, but we are very uncertain about the results. Colchicine may increase the risk of diarrhea. For every 10 people treated with colchicine, 1 extra person may get diarrhea, compared to those not taking colchicine.\n\nWhat are the limitations of this evidence?\nThe evidence is limited because the studies were very small, and in some studies, participants may have known which treatment they were getting. This can introduce bias, because people's expectations can influence the results, making them less reliable. Also, the studies did not include a wide variety of people or look at all the health outcomes that are important to patients.\n\nHow up to date is this evidence?\nThe evidence is up to date to May 2023.",
  "metrics": [
    {
      "linguistic_evaluation": {
        "words": {
          "value": 682,
          "rating": "within_limit",
          "direction": null,
          "feedback": null
        },
        "sentences": {
          "value": 35,
          "rating": "info",
          "direction": null,
          "feedback": null
        },
        "words_per_sentence": {
          "value": 19.485714285714284,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "passive_voice": {
          "value": 16,
          "rating": "P75",
          "direction": "lower_better",
          "feedback": null
        },
        "active_voice": {
          "value": 65,
          "rating": "P75",
          "direction": "higher_better",
          "feedback": null
        },
        "pronouns": {
          "value": 47,
          "rating": "P75",
          "direction": "higher_better",
          "feedback": null
        },
        "nominalization": {
          "value": 17,
          "rating": "P75",
          "direction": "lower_better",
          "feedback": null
        },
        "nouns": {
          "value": 176,
          "rating": "P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 176.0 to <116.0 (median)"
        },
        "flesch_reading_ease": {
          "value": 58.79248387096777,
          "rating": "P75",
          "direction": "higher_better",
          "feedback": null
        },
        "flesch_kincaid_grade": {
          "value": 9.899751152073733,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "automated_readability_index": {
          "value": 10.674997905320488,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "coleman_liau_index": {
          "value": 10.598005865102639,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "gunning_fog_index": {
          "value": 13.483435274403016,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "lix": {
          "value": 44.8522832006703,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "rix": {
          "value": 4.942857142857143,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "smog_index": {
          "value": 12.591663046625438,
          "rating": "P75",
          "direction": "lower_better",
          "feedback": null
        },
        "dale_chall_readability": {
          "value": 6.268412249685799,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "complex_words_dc": {
          "value": 229,
          "rating": "P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 229.0 to <160.0 (median)"
        },
        "complex_words": {
          "value": 97,
          "rating": "P75",
          "direction": "lower_better",
          "feedback": null
        },
        "long_words": {
          "value": 173,
          "rating": "P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 173.0 to <122.0 (median)"
        }
      },
      "word_count_status": {
        "word_count": 682,
        "limit": 850,
        "status": "within_limit",
        "message": "Word count: 682 ✓ WITHIN LIMIT (≤850 words)"
      },
      "summary": {
        "P25_count": 8,
        "P50_count": 0,
        "P75_count": 7,
        "P90_count": 3,
        "P10_count": 0,
        "BEYOND_P90_count": 0,
        "BELOW_P10_count": 0,
        "total_evaluated": 18,
        "P25_percentage": 44.44444444444444,
        "P50_percentage": 0,
        "P75_percentage": 38.88888888888889,
        "P90_percentage": 16.666666666666664,
        "P10_percentage": 0,
        "BEYOND_P90_percentage": 0,
        "BELOW_P10_percentage": 0,
        "best_quartile_rate": 83.33333333333334,
        "overall_assessment": "HIGHLY CONFORMS TO TYPICAL PLS PATTERNS"
      }
    }
  ],
  "evaluation": [
    {
      "grade": "NOT_APPROVED",
      "feedback": "This is a strong draft that passes all critical checks for accuracy, completeness, and length. The feedback below focuses on 3 key areas to make the text even clearer for readers by simplifying sentence structure and vocabulary.\n\n1. **Introduce the technical term for the disease.** Readers often look for the technical term to connect the summary with other information. The current heading is a bit long and uses the definition instead of the term itself.\n    - **Current text:** \"What are heart and blood vessel problems caused by clogged arteries?\"\n    - **Problem:** This is a long heading, and it misses the opportunity to teach the reader the medical term used in the main review.\n    - **Suggestion:** Change the subheading to: **\"What is atherosclerotic cardiovascular disease?\"** Then, start the paragraph with: \"Atherosclerotic cardiovascular disease is a condition where arteries get clogged by fatty substances...\"\n\n2. **Break up a very long and complex sentence.** One sentence in the methods section is nearly 50 words long and contains too many different ideas.\n    - **Current text:** \"We wanted to assess the benefits and harms of using colchicine to prevent cardiovascular events in people who have not had any of these problems before. We compared colchicine to a placebo (a dummy pill), other medicines that affect the body's immune system (called immunomodulating medications), or usual care to see if it could reduce the risk of cardiovascular outcomes like death from any cause, non-fatal heart attacks, stroke, and adverse events.\"\n    - **Problem:** This sentence lists the population, intervention, comparison, and outcomes all at once, which is overwhelming.\n    - **Suggestion:** Break it into shorter, more focused sentences. For example: \"We wanted to find out the benefits and harms of using colchicine to prevent cardiovascular events in people who have not had these problems before. We looked at studies that compared colchicine with a placebo (a dummy pill), other medicines that affect the immune system, or usual care. We checked the effects on outcomes like death, heart attacks, strokes, and side effects.\"\n\n3. **Simplify noun-heavy phrasing to be more direct.** Some sentences rely on abstract nouns, which can make them harder to understand than sentences that use more active verbs.\n    - **Current text:** \"It is a leading cause of death and disability around the world, putting a strain on healthcare systems and affecting the quality of life for millions of people.\"\n    - **Problem:** This phrasing is less direct. Using verbs makes the impact clearer.\n    - **Suggestion:** Rewrite to use more verbs. For example: \"This condition causes many deaths and disabilities worldwide. It strains healthcare systems and affects the quality of life for millions of people.\"\n\nThese changes will help address the vocabulary complexity and noun-heavy sentences flagged in the evaluation report, making an already good summary even more accessible.",
      "pls_evaluation_summary": "The evaluation shows this draft highly conforms to typical PLS patterns, with 83% of its features falling within the best quartile for readability and style. However, the analysis also flags three areas for potential improvement: the number of nouns, Dale-Chall complex words, and long words are all in the 90th percentile range. This suggests that focusing on simplifying vocabulary and converting noun-heavy phrases into more direct, verb-based sentences would be the most effective way to enhance clarity."
    }
  ]
}